Vivek Subbiah has been appointed as the inaugural associate director for drug development and precision oncology at the Stanford Cancer Institute, with a planned start date in spring 2026.
Daniela E. Matei, an expert in ovarian cancer treatment and research, will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search.
